Cargando…

1161: PERSISTENT IMMUNE CELL ABNORMALITIES IN THE INTESTINAL MUCOSA OF PATIENTS AFTER RECOVERY FROM COVID-19 INFECTION

Detalles Bibliográficos
Autores principales: Meringer, Hadar, Tokuyama, Minami, Tankelevich, Michael, Martinez-Delgado, Gustavo, Jha, Divya, Livanos, Alexandra E., Canales-Herrerias, Pablo, Cossarini, Francesca, Mehandru, Saurabh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AGA Institute. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212688/
http://dx.doi.org/10.1016/S0016-5085(22)60655-3
_version_ 1784730661438881792
author Meringer, Hadar
Tokuyama, Minami
Tankelevich, Michael
Martinez-Delgado, Gustavo
Jha, Divya
Livanos, Alexandra E.
Canales-Herrerias, Pablo
Cossarini, Francesca
Mehandru, Saurabh
author_facet Meringer, Hadar
Tokuyama, Minami
Tankelevich, Michael
Martinez-Delgado, Gustavo
Jha, Divya
Livanos, Alexandra E.
Canales-Herrerias, Pablo
Cossarini, Francesca
Mehandru, Saurabh
author_sort Meringer, Hadar
collection PubMed
description
format Online
Article
Text
id pubmed-9212688
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AGA Institute. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92126882022-06-22 1161: PERSISTENT IMMUNE CELL ABNORMALITIES IN THE INTESTINAL MUCOSA OF PATIENTS AFTER RECOVERY FROM COVID-19 INFECTION Meringer, Hadar Tokuyama, Minami Tankelevich, Michael Martinez-Delgado, Gustavo Jha, Divya Livanos, Alexandra E. Canales-Herrerias, Pablo Cossarini, Francesca Mehandru, Saurabh Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212688/ http://dx.doi.org/10.1016/S0016-5085(22)60655-3 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle AGA Abstracts
Meringer, Hadar
Tokuyama, Minami
Tankelevich, Michael
Martinez-Delgado, Gustavo
Jha, Divya
Livanos, Alexandra E.
Canales-Herrerias, Pablo
Cossarini, Francesca
Mehandru, Saurabh
1161: PERSISTENT IMMUNE CELL ABNORMALITIES IN THE INTESTINAL MUCOSA OF PATIENTS AFTER RECOVERY FROM COVID-19 INFECTION
title 1161: PERSISTENT IMMUNE CELL ABNORMALITIES IN THE INTESTINAL MUCOSA OF PATIENTS AFTER RECOVERY FROM COVID-19 INFECTION
title_full 1161: PERSISTENT IMMUNE CELL ABNORMALITIES IN THE INTESTINAL MUCOSA OF PATIENTS AFTER RECOVERY FROM COVID-19 INFECTION
title_fullStr 1161: PERSISTENT IMMUNE CELL ABNORMALITIES IN THE INTESTINAL MUCOSA OF PATIENTS AFTER RECOVERY FROM COVID-19 INFECTION
title_full_unstemmed 1161: PERSISTENT IMMUNE CELL ABNORMALITIES IN THE INTESTINAL MUCOSA OF PATIENTS AFTER RECOVERY FROM COVID-19 INFECTION
title_short 1161: PERSISTENT IMMUNE CELL ABNORMALITIES IN THE INTESTINAL MUCOSA OF PATIENTS AFTER RECOVERY FROM COVID-19 INFECTION
title_sort 1161: persistent immune cell abnormalities in the intestinal mucosa of patients after recovery from covid-19 infection
topic AGA Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212688/
http://dx.doi.org/10.1016/S0016-5085(22)60655-3
work_keys_str_mv AT meringerhadar 1161persistentimmunecellabnormalitiesintheintestinalmucosaofpatientsafterrecoveryfromcovid19infection
AT tokuyamaminami 1161persistentimmunecellabnormalitiesintheintestinalmucosaofpatientsafterrecoveryfromcovid19infection
AT tankelevichmichael 1161persistentimmunecellabnormalitiesintheintestinalmucosaofpatientsafterrecoveryfromcovid19infection
AT martinezdelgadogustavo 1161persistentimmunecellabnormalitiesintheintestinalmucosaofpatientsafterrecoveryfromcovid19infection
AT jhadivya 1161persistentimmunecellabnormalitiesintheintestinalmucosaofpatientsafterrecoveryfromcovid19infection
AT livanosalexandrae 1161persistentimmunecellabnormalitiesintheintestinalmucosaofpatientsafterrecoveryfromcovid19infection
AT canalesherreriaspablo 1161persistentimmunecellabnormalitiesintheintestinalmucosaofpatientsafterrecoveryfromcovid19infection
AT cossarinifrancesca 1161persistentimmunecellabnormalitiesintheintestinalmucosaofpatientsafterrecoveryfromcovid19infection
AT mehandrusaurabh 1161persistentimmunecellabnormalitiesintheintestinalmucosaofpatientsafterrecoveryfromcovid19infection